SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 1

Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis

Sevgi İrtegün KANDEMİR
Abdullah Zübeyir DAĞLI
Kemal NAS
Irmak İçen TAŞKIN
Pages
20–25
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The results of this study showed that the ADAMTS8 level was significantly elevated in the serum of PsA patients(160.9±49.79 pg/mL) compared to the control groups (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis.
📊
Key Findings & Data:The aim of this study was to determine the serum levels ofADAMTS4 and ADAMTS8 in PsA patients.
💡
Conclusion & Impact:Results: The results of this study showed that the ADAMTS8 level was significantly elevated in the serum of PsA patients(160.9±49.79 pg/mL) compared to the control groups (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis. A disintegrin and metallopro teinase with thrombospondin motifs (ADAMTS) is a large family of proteoglycanase enzymes that show proteolytic activity.The expression levels of ADAMTS proteases in osteoarthritis and rheumatoid arthritis are upregulated. However, theirexpression levels in PsA patients have not been examined yet. The aim of this study was to determine the serum levels ofADAMTS4 and ADAMTS8 in PsA patients. Materials and Methods: This was a case-control study and enrolled 40 PsA patients and 40 individuals as controls. Serumlevels of ADAMTS4 and ADAMTS8 were examined by the enzyme-linked immunosorbent assay (ELISA). The relationshipbetween ADAMTS8 levels and demographic and clinical features of PsA patients were analyzed. Results: The results of this study showed that the ADAMTS8 level was significantly elevated in the serum of PsA patients(160.9±49.79 pg/mL) compared to the control groups (

🔖

Cite This Article

KANDEMİR, S. İ., DAĞLI, A. Z., NAS, K., TAŞKIN, I. İ. (2022). Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal, Cilt: 43 - Sayı: 1, 20–25. https://ajindex.com/articles/502289

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361(5): 496–509
  2. Lønnberg AS, Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Rev Clin Immunol 2017; 13(1): 27–34
  3. Mathew AJ, Chandran V. Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation. Rheumatol Ther 2020; 7(2): 287–300
  4. Lorenzo A, Pardo E, Charca L, Pino M, Queiro R. Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis. Clin Rheumatol 2020; 39(10): 2973–9
  5. Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat 2020; 31(7): 662–79
  6. Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, et al. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists’ offices. J Dermatolog Treat 2006; 17(5): 279–87
  7. Rida MA, Chandran V. Challenges in the clinical diagnosis of psoriatic arthritis. Clin Immunol 2020;214: 108390
  8. Stanton H, Melrose J, Little CB, Fosang AJ. Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta 2011; 1812(12): 1616–29
  9. Salter RC, Ashlin TG, Kwan AP, Ramji DP. ADAMTS proteases: key roles in atherosclerosis?. J Mol Med (Berl) 2010; 88(12): 1203–11
  10. Wågsäter D, Björk H, Zhu C, Björkegren J, Valen G, Hamsten A, et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 2008; 196(2): 514–22
  11. Botter SM, Glasson SS, Hopkins B, Clockaerts S, Weinans H, van Leeuwen JP, et al. ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes. Osteoarthritis Cartilage 2009; 17(5): 636–45
  12. Bondeson J, Wainwright S, Hughes C, Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol 2008; 26(1): 139–45
  13. Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 2002; 277(25): 22201–8
  14. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64(Suppl 2): ii3–8
  15. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remiss